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INTRODUCTION
Hepatitis B virus (HBV) infection is highly prevalent in
Africa and Asia, and in the different countries, the infection
rate ranges from 5% to 20%. In Korea, its prevalence has
been decreasing since the HBV vaccination was introduced
about 20 yr ago. Nevertheless, HBV infection still ranges
from 2 to 8.9% (2-12), which is higher than in the United
States and Western Europe (1). Health care workers (HCWs)
in Korea are at risk for getting an infection with HBV; there-
fore, HBV vaccination has been strongly recommended for
them. However, studies on the HBV markers for HCWs in
Korea are rare. This study was initiated to determine the
seroprevalence of HBsAg, anti-HBs and anti-HBc in HCWs
in Korea. This study was approved by the institutional review
board at our hospital. 
MATERIALS AND METHODS
Surveillance of HBV vaccination history
The study was performed at Sanggye Paik Hospital, which
is a 700-bed university-affiliated tertiary hospital located in
the northeast section of Seoul. Of the 725 HCWs working
at the hospital in December, 2003, 571 of them participated
in a cross-sectional HBV viral marker study and they replied
to the surveillance questionnaires we gave them about their
previous HBV vaccinations. The participant distributions
according to age, sex and occupations are listed in Table 1.
Of the 571 HCWs (123 males and 448 females), 289 (50.6%)
were nurses and 466 (81.6%) were under 40 yr of age. The
compliance rates according to the occupation were 33.7%
(56/166) for physicians, 99.7% (289/290) for nurses, 79.6%
(113/142) for aid-nurses and 89.0% (113/127) for techni-
cians; the total compliance rate was 78.8%. Anyone inocu-
lated at least once was classified as the vaccinated group:
according to the number of doses, they were divided into
the complete (3 or more) and incomplete (1 or 2) vaccinated
groups. 
Study on HBsAg, anti-HBs and anti-HBc, IgG 
A total of 571 samples were tested for HBsAg and anti-
HBs with using electrochemiluminescence immunoassay
(Elecsys 2010, Roche, Mannheim, German). Samples with
a cutoff index greater than or equal to 1.0 were considered
positive for HBsAg, and 10 mIU/mL was set as the minimal
protective level (positive) of anti-HBs. For the tests for anti-
HBc with using a chemiluminescence enzyme immunoassay
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Seroprevalence of Hepatitis B Virus among Health Care Workers in
Korea
We studied the seroprevalence of HBsAg, anti-HBs and anti-HBc and the vaccina-
tion histories among health care workers (HCWs) at a large suburban referral hos-
pital in Korea. The purpose of this study was to determine the immune status of
HCWs against hepatitis B virus and we also wanted to prepare a practical guideline
to protect HCWs from occupational exposure. During December, 2003, 571 HCWs
(56 physicians, 289 nurses, 113 technicians and 113 aid-nurses) aged between
21 and 74 yr were included in the surveillance. The positive rates of HBsAg and
anti-HBs were 2.4% (14/571) and 76.9% (439/571), respectively. The positive rate
of anti-HBs was lower in the physician group, and this was associated with the male
gender and older age. Of the 439 anti-HBs positive cases, 320 cases (73.1%) were
anti-HBc negative and this was significantly associated with a past history of HBV
vaccination. The distribution of the anti-HBs levels was not associated with age
(except for HCWs in their sixties), gender or occupation. Our study revealed that
the seroprevalence rates of HBsAg and anti-HBs in HCWs in Korea were not dif-
ferent from those of the general population. Based on this surveillance, we can make
reasonable decisions in case of occupational exposure to hepatitis B virus.
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(ADVIA, Centaur, Bayer, Tarry town, NY, U.S.A.), the speci-
mens with index values greater than 1.0 were considered
positive. 
All statistical analysis was done using SPSS for Window
software, version 11.5.
RESULTS
Participant distributions according to HBsAg and anti-HBs 
The overall positive rates of HBsAg and anti-HBs were
2.4% (14/571) and 76.9% (439/571), respectively (Table 2,
3). A number of HBsAg and anti-HBs co-negative cases were
118 (20.7%). The positive rates of HBsAg among the male
and female groups were the same (2.4%); however, the posi-
tive rate of anti-HBs was higher in the females (79.5%) than
in the males (67.5%) (odds ratio: 0.43, p value: 0.003 by chi-
square test). According to occupations, the positive rate of
HBsAg was the highest in the nurse group (3.1%). The posi-
tive rate of anti-HBs was the highest in the nurse group (79.6
%) and the lowest in the physician group (64.3%). The odds
ratios for the nurses, technicians and aid-nurses were slightly
elevated, but this was statistically insignificant. According
to age, the positive rates of both HBsAg and anti-HBs were
the highest for the HCW in their thirties, and the positive
rate of anti-HBs was the lowest for the HCW in their six-
ties (odds ratio: 1.04, pvalue: 0.01). 
Anti-HBs titers according to age, gender and occupation 
Among the 439 anti-HBs positive cases, 321 cases (73.1%)
had greater than a 100 mIU/mL level of anti-HBs (Table 4).
The anti-HBs titers from 100 mIU/mL to <1,000 mIU/mL
had the same prevalence among all the age groups (except
those workers older than 60) and all the occupational groups.
The anti-HBs titers from 10 mIU/mL to <100 mIU/mL
were prevalent in HCW in their sixties. The anti-HBs titers
greater than 1,000 mIU/mL were prevalent in the physician
and nurse groups, compared with the aid-nurse and techni-
cian groups (25% and 23.2% vs. 17.7% and 12.4%, respec-
tively). 
HBsAg, anti-HBs, anti-HBc and HBV vaccination history 
Of the 571 cases, only 151 cases (26.4%) showed anti-HBc
positivity and 78.1% (118/151) of them were positive for
anti-HBs (Table 5). Among the 420 anti-HBc negative cases,
321 cases (76.4%) were positive for anti-HBs. Therefore, in
the 439 anti-HBs positive cases, the rate of infection-induced
(anti-HBc positive) anti-HBs was 26.9% and the rate of vac-
No. (%) of participants according to age (yr)
20-29 30-39 40-49 50-59 >60 Total
Gender
Male 14 (11.4) 59 (48.0) 37 (30.1) 9 (7.3) 4 (3.3) 123 (100)
Female 178 (39.7) 215 (48.0) 34 (7.6) 19 (4.2) 2 (0.4) 448 (100)
Occupations
Physician 7 (12.5) 22 (39.3) 16 (28.6) 7 (12.5) 4 (7.1) 56 (100)
Nurse 124 (42.9) 136 (47.1) 19 (6.6) 10 (3.5) 0 (0) 289 (100)
Technician 27 (23.9) 63 (55.8) 22 (19.5) 1 (0.9) 0 (0) 113 (100)
Aid-nurse  34 (30.1) 53 (46.9) 14 (12.4) 10 (8.8) 2 (1.8) 113 (100)
Total 192 (33.6) 274 (48.0) 71 (12.4) 28 (4.9) 6 (1.1) 571 (100)
Table 1. Participant distributions according to age, gender and occupation
HBsAg (+)/
Anti-HBs (-)
HBsAg (-)/
Anti-HBs (+)
HBsAg (-)/
Anti-HBs (-)
Total
Gender
Male 3 (2.4%) 83 (67.5%) 37 (30.1%) 123 (100%)
Female 11 (2.4%) 356 (79.5%) 81 (18.1%) 448 (100%)
Age (yr)
20-29 5 (2.6%) 138 (71.9%) 49 (25.5%) 192 (100%)
30-39 8 (2.9%) 222 (81.0%) 44 (16.1%) 274 (100%)
40-49 1 (1.4%) 53 (74.6%) 17 (23.9%) 71 (100%)
50-59 0 (0%) 22 (78.6%) 6 (21.4%) 28 (100%)
>60 0 (0%) 4 (66.7%) 2 (33.3%) 6 (100%)
Occupation
Physician 0 (0%) 36 (64.3%) 20 (35.7%) 56 (100%)
Nurse 9 (3.1%) 230 (79.6%) 50 (17.3%) 289 (100%)
Technician 2 (1.8%) 88 (77.9%) 23 (20.4%) 113 (100%)
Aid-nurse 3 (2.7%) 85 (75.2%) 25 (22.1%) 113 (100%)
Total 14 (2.4%) 439 (76.9%) 118 (20.7%) 571 (100%)
Table 2. Participant distributions according to the HBsAg and
anti-HBs results 
Variables Odds ratio 95% CI p value
Gender
Female 1.00
Male 0.43 (0.22-0.86) 0.02
Age 1.04 (1.01-1.07) 0.01
Occupations
Physicians 1.00
Nurses 1.45 (0.60-3.53) 0.41
Technicians 1.90 (0.89-4.05) 0.10
Aid-nurses 1.18 (0.49-2.83) 0.71
Table 3. Multivariate logistic regression for the anti-HBs60 B.-M. Shin, H.M. Yoo, A.S. Lee, et al.
cine-induced (anti-HBc negative) anti-HBs was 73.1%. The
number of vaccine doses and the anti-HBs positive rates were
significantly associated in the anti-HBc negative group (p=
0.01, chi-square test). Any HBsAg positive case was not
observed in the anti-HBc negative group, in contrast to the
9.3% HBsAg positive rate (14/151) in the anti-HBc positive
group. In the HBsAg (-)/anti-HBs (+)/anti-HBc (-) group,
there were 50 cases noted that had no vaccination history. In
the anti-HBs (+)/anti-HBc (+) group, 41 cases had a history
of more than 3 vaccine doses, and 4 of them even showed to
be positive for HBsAg.
DISCUSSION
The prevalence rate of HBsAg in Korea is known to be
about 2-8.9%, and this rate has decreased in the past 20 yr
since HBV vaccination was introduced (2-12). The positive
rate for HBsAg in our study is 2.4%. A study carried out in
2003 revealed that the prevalence rates of HBsAg in Korea
showed a decreasing tendency from 1.9% in adults to 0.2-
0.3% in elementary school children (5). Therefore, the posi-
tive rate in our study showed results similar to the study done
in 2003. Several studies have been performed in the moder-
ate HBV-endemic areas, and they reported the HBV preva-
lence in HCWs as ranging from 2.8% to 9.7% (13-15). The
overall anti-HBs positive rate in the present study was 76.9%,
and it was similar to the anti-HBs positive rate in the gen-
eral Korean population (2-4, 7). 
The compliance rate of our surveillance was 78.8%. How-
ever, it varied according to the occupation (33.7-99.7%) and
it was lowest in the physicians group (33.7%). The main
reason for this might be that the physicians were ‘too busy
to participate in a study’ as was observed in another study
(16). The physician group showed the lowest anti-HBs pos-
itive rate among the occupational groups. Possibly the higher
HBsAg (-)/anti-HBs (-) rate was due to the relatively older
age distribution than was seen for the other groups. In the
physician group, 48.2% were older than 40 yr of age and
only 63% of them was anti-HBs positive, which was below
the overall anti-HBs rate. The positive rates of HBsAg and
anti-HBs in the nurse group were the highest among the
occupational groups. This suggested that the nurse group
has more chances to be exposed to the needle stick injury or
other infectious body fluid from patients than did the other
occupational groups (17, 18), because most of these exposures
occur during the disposal of used syringes and recapping (19).
Subjects with anti-HBs levels above 100 mIU/mL were re-
garded as good responders and this titer was usually followed
by long-term immunity (20-23). Persistence of anti-HBs is
known to be related to the maximum antibody level (20, 21).
Although our study was a cross-sectional study and the anti-
Anti-HBs titers <10 10-<100 100-<1,000 >1,000 Total
Age (yr)
20-29 54 (28.1%) 38 (19.8%) 59 (30.7%) 41 (21.4%) 192 (100%)
30-39 52 (19.0%) 54 (19.7%) 110 (40.1%) 58 (21.2%) 274 (100%)
40-49 18 (25.4%) 17 (23.9%) 29 (40.8%) 7 (9.9%) 71 (100%)
50-59 6 (21.4%) 6 (21.4%) 9 (32.1%) 7 (25.0%) 28 (100%)
>60 2 (33.3%)  3 (50.0%) 1 (16.7%) 0 (0%) 6 (100%)
Gender
Male 40 (32.5%) 23 (18.7%) 40 (32.5%) 20 (16.3%) 123 (100%)
Female 92 (20.5%) 95 (21.2%) 168 (37.5%) 93 (20.8%) 448 (100%)
Occupation
Physician 20 (35.7%) 7 (12.5%) 16 (28.6%) 13 (23.2%) 56 (100%)
Nurse 59 (20.4%) 56 (19.4%) 108 (37.4%) 66 (22.8%) 289 (100%)
Technician 25 (22.1%) 23 (20.4%) 51 (45.1%) 14 (12.4%) 113 (100%)
Aid-nurse 28 (24.8%) 32 (28.3%) 33 (29.2%) 20 (17.7%) 113 (100%)
Total 132 (23.1%) 118 (20.7%) 208 (36.4%) 113 (19.8%) 571 (100%)
Table 4. Distribution of anti-HBs titers according to age/gender and occupation
Anti-HBc (-)
Dose HBsAg (+)/
anti-HBs (-)
HBsAg (-)/
anti-HBs (+)
HBsAg (-)/
anti-HBs (-)
Total
Anti-HBc (+)
HBsAg (+)/
anti-HBs (-)
HBsAg (-)/
anti-HBs (+)
HBsAg (-)/
anti-HBs (-)
0 0 50 (15.6%) 29 (29.3%) 5 (35.7%) 50 (42.4%) 4 (21.1%) 138 (24.2%)
1-2 0 111 (34.6%) 40 (40.4%) 2 (14.3%) 27 (22.9%) 8 (42.1%) 188 (32.9%)
≥3 0 140 (43.6%) 25 (25.3%) 4 (28.6%) 36 (30.5%) 1 (5.3%) 206 (36.1%)
Not available 0 20 (6.2%) 5 (5.1%) 3 (21.4%) 5 (4.2%) 6 (31.6%) 39 (6.8%)
Total 0 321 (100%) 99 (100%) 14 (100%) 118 (100%) 19 (100%) 571 (100%)
Table 5. Results of HBsAg, anti-HBs, anti-HBc and vaccination historySeroprevalence of HBV among Healthcare Workers 61
HBs titers were not at the peak level after a basic course of
vaccination, the subjects with a titer higher than 100 mIU/
mL anti-HBs seem to be meaningful. This is because the
subjects that develop higher anti-HBs titers will retain anti-
body for a longer period than those subjects with lower levels
of antibody. It has been reported that once a level above 10
mIU/mL anti-HBs is acquired, it is unnecessary to give a
booster dose even when the anti-HBs level falls below 10
mIU/mL (24). 
We must consider the distribution of anti-HBs in relation
to the anti-HBc and the vaccination history. Anti-HBc is a
remarkable marker to differentiate vaccine-induced anti-HBs
from infection-induced anti-HBs. Although no difference
was found between the anti-HBc positive and negative groups
for the anti-HBs positive rates, the anti-HBs in our HCWs
were mainly acquired from vaccination (73.1%). In our study,
the positive rate of anti-HBc was 26.4% (151/571) and the
rate of the anti-HBc-alone positive cases was 3.3%. The posi-
tive rates of anti-HBc in the all the study cases/anti-HBc-
alone in Korea have been variably reported; 55.8/19% in
1985 (2), 24.9/1.9% in 1997 (3) and 57.2/5.1% in 2000 (4).
The subjects of the studies done in 1985 and 2000 were mainly
adults who were aged more than 40 yr old. However, those
subjects in the 1997 study and in our study included more of
the younger generation Koreans who were in their twenties
and thirties. A study done in 1994 (25) showed similar anti-
HBs positive rates between the vaccinated and non-vacci-
nated groups, but another study done in 2000 revealed a
higher anti-HBs positive rate in the vaccinated group in
Korea (4). A study done in the South Africa revealed that
the anti-HBs positive rate in HCWs was 36.6% and only
21.2% of them had a history of past immunization against
HBV (26). The anti-HBs seropositivity in Turkish HCWs
was reported as 68.4% (13). The seroprevalence of anti-HBc
was reported as 32% in Yemen HCWs (27). Therefore, the
seroprevalence rates of HBsAg and anti-HBs in Korean HCWs
were similar with the prevalence rates in the general Korean
population, but the Korean HCWs had lower HBsAg rates
and higher anti-HB rates than did the HCWs in the HBV
endemic Korea.
Out of 571 cases, 532 cases replied to the questionnaires
about HBV vaccination and 74.1% (394/532) of them had
previous vaccination histories (206 complete and 188 incom-
plete). However, 19.8% (78/394) of the vaccinated cases
were anti-HBc positive and incomplete vaccination might
be one of the reasons for this. Some Korean adults might
have taken a HBV vaccination dose during a latent period
or a window period after their HBV infections. They even
had a vaccination dose after the acquisition of infection-induced
anti-HBs with or without a HBV viral maker study for the
booster doses. The 50 cases showing HBsAg (-)/anti-HBs
(+)/anti-HBc (-)/vaccination (-) results could not be explained
well. Incorrect memories or unreliable answers to the surveil-
lance questionnaires about their vaccinations could be the
reason. The vaccination done in childhood could be a reason
for their incorrect memories. Such results were also observed
in other study, in which 10.2% of HBsAg (-)/anti-HBs (+)/
anti-HBc (-) cases had no previous vaccination histories (4). 
In conclusion, 76.9% of HCWs in a Korean hospital were
positive for anti-HBs and 73.1% of them had an anti-HBs
level of more than 100 mIU/mL, which suggests long last-
ing immunity. About 25% of HCWs may need vaccination
against HBV infection in case of HBV exposure, such as could
happen with a needle stick injury (28). 
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